Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Core Scientific (CORZ) EBITDA Margin (2021 - 2025)

Historic EBITDA Margin for Core Scientific (CORZ) over the last 5 years, with Q3 2025 value amounting to 70.81%.

  • Core Scientific's EBITDA Margin fell 275800.0% to 70.81% in Q3 2025 from the same period last year, while for Sep 2025 it was 49.7%, marking a year-over-year decrease of 541000.0%. This contributed to the annual value of 3.76% for FY2024, which is 55400.0% down from last year.
  • Per Core Scientific's latest filing, its EBITDA Margin stood at 70.81% for Q3 2025, which was down 275800.0% from 33.43% recorded in Q2 2025.
  • In the past 5 years, Core Scientific's EBITDA Margin ranged from a high of 33.85% in Q4 2021 and a low of 637.54% during Q2 2022
  • Its 5-year average for EBITDA Margin is 81.54%, with a median of 10.67% in 2023.
  • Per our database at Business Quant, Core Scientific's EBITDA Margin crashed by -6581600bps in 2022 and then soared by 6450000bps in 2023.
  • Core Scientific's EBITDA Margin (Quarter) stood at 33.85% in 2021, then crashed by -1650bps to 524.6% in 2022, then soared by 101bps to 2.77% in 2023, then tumbled by -1612bps to 41.91% in 2024, then tumbled by -69bps to 70.81% in 2025.
  • Its EBITDA Margin was 70.81% in Q3 2025, compared to 33.43% in Q2 2025 and 53.56% in Q1 2025.